In plain words

Three of the four small randomized trials found lower fatigue with rhodiola extract than with a placebo. The fourth suggested this happens only under certain stressful conditions. A 2012 review, which may include these trials, judged the studies it read too weak to say either way.

The short answer

Three of the four randomized trials found lower fatigue than with placebo: one dose in 161 cadets (2003), 576 mg a day for 28 days in 60 adults with stress-related fatigue (2008), and a low dose for 20 days (2000; the ledger has no n). The fourth, 56 people on one low-dose tablet a day for two weeks, suggested less fatigue only under certain stressful conditions (2000). A before-after study of 100 people found fatigue lower after 8 weeks at 2 × 200 mg, a possible effect. Certainty is very low: a 2012 review that may include these trials judged all its studies at high or unclear risk of bias.

The 60-second version

Every study in the video is listed below, with its quote.

Watch on YouTube

Where the evidence sits

Less fatigue

■ Randomized trial, Shevtsov et al., 2003 · 161 people · single dose · also reported by EBSCO Research Starters
■ Randomized trial, Olsson et al., 2008 · 60 people · 28 days
■ Randomized trial, Spasov et al., 2000 · ledger has no n · 20 days
■ Before-after study, Lekomtseva et al., 2017 · 100 people · 8 weeks
□ Pooled analysis reported by EBSCO Research Starters · may include trials listed here · no new data

Evidence insufficient

□ Reported by: EBSCO Research Starters; Ishaque et al., 2012 · no new data

Less fatigue only under some stress

■ Randomized trial, Darbinyan et al., 2000 · 56 people · 2 weeks

■ measured by the source's own study · ◪ pooled analysis, may overlap studies counted here · □ reported, reviewed or argued, no new data

Evidence weight6363 / 100?

Who says what

SourceFindingDesignPeopleDose and lengthFunding and independence
Shevtsov et al., 2003Less fatigueRandomized trial161 cadetsOnceNot in ledger
Olsson et al., 2008Better burnout scoreRandomized trial60, stress-related fatigue576 mg daily, 28 daysNot in ledger
Spasov et al., 2000Better; dose probably lowRandomized trialNot in ledgerLow dose, 20 daysNot in ledger
Darbinyan et al., 2000Only under certain stressRandomized trial56Low dose, 2 weeksNot in ledger
Lekomtseva et al., 2017Lower than startBefore-after, uncontrolled100, chronic fatigue2×200 mg, 8 weeksNot in ledger
Ishaque et al., 2012Insufficient evidenceReview; may include trials aboveNoneNot in ledgerNot in ledger
EBSCO Research StartersSupportive; doubts settingEncyclopedia describing trialsNoneNot in ledgerNot in ledger
Shevtsov et al., 2003

Less fatigue

Design
Randomized trial
People
161 cadets
Dose and length
Once
Funding
Not in ledger
Olsson et al., 2008

Better burnout score

Design
Randomized trial
People
60, stress-related fatigue
Dose and length
576 mg daily, 28 days
Funding
Not in ledger
Spasov et al., 2000

Better; dose probably low

Design
Randomized trial
People
Not in ledger
Dose and length
Low dose, 20 days
Funding
Not in ledger
Darbinyan et al., 2000

Only under certain stress

Design
Randomized trial
People
56
Dose and length
Low dose, 2 weeks
Funding
Not in ledger
Lekomtseva et al., 2017

Lower than start

Design
Before-after, uncontrolled
People
100, chronic fatigue
Dose and length
2×200 mg, 8 weeks
Funding
Not in ledger
Ishaque et al., 2012

Insufficient evidence

Design
Review; may include trials above
People
None
Dose and length
Not in ledger
Funding
Not in ledger
EBSCO Research Starters

Supportive; doubts setting

Design
Encyclopedia describing trials
People
None
Dose and length
Not in ledger
Funding
Not in ledger

What did placebo trials find?

Shevtsov and colleagues (2003) gave 161 cadets under stress one dose of SHR-5 extract (2 or 3 capsules) or a placebo:

This was statistically highly significant (p < 0.001) for both doses

Olsson and colleagues (2008) gave 60 adults with stress-related fatigue 576 mg a day or a placebo for 28 days:

significant effects of the SHR-5 extract in comparison with the placebo were observed in Pines' burnout scale

Did dose or setting matter?

Spasov and colleagues (2000) gave a low dose for 20 days; the ledger has no n for this trial. They concluded that

the study drug gave significant results compared to the placebo group but that the dose level probably was suboptimal.

Darbinyan and colleagues (2000) gave 56 people one low-dose tablet a day for two weeks:

These results suggest that RRE can reduce general fatigue under certain stressful conditions.

Does it last past 28 days?

Lekomtseva and colleagues (2017) gave 100 people with prolonged or chronic fatigue 2 × 200 mg for 8 weeks, with no control group, and found fatigue significantly lower at week 8 than at the start:

The greatest change was observed after 1 week of treatment.

How do reviewers read the trials?

Ishaque and colleagues (2012) reviewed 11 studies, which may include the trials above, rating all at high or unclear risk of bias:

Two of six trials examining physical fatigue in healthy populations report R. rosea to be effective as did three of five RCTs evaluating R. rosea for mental fatigue.

EBSCO Research Starters notes that the supporting trials come from former Soviet republics with a pattern of overly positive results:

only if confirmation is obtained in a more reliable setting can rhodiola be considered to have real supporting evidence behind it.

Why the sources disagree

The trials differ in people and span: cadets after one dose, adults with stress-related fatigue over 28 days, and people with chronic fatigue over 8 weeks, compared only with their own starting point. Spasov's authors thought their dose too low. Ishaque and EBSCO re-read studies that may include the trials above: Ishaque weighs trial quality, and EBSCO doubts where the trials were run. The ledger has no funding information for any of them.

What would settle it

An independent, pre-registered, placebo-controlled trial of a standardized extract at a fixed dose for at least 12 weeks in adults with stress-related fatigue, run outside the former Soviet republics, scoring fatigue on a validated scale at 1, 4 and 12 weeks and 4 weeks after stopping. A matching result from a second group would raise certainty.

How this page was made

The 7 sources are five fatigue studies and one systematic review from a PubMed literature search, plus the EBSCO Research Starters summary. Studies of exercise and depression were left out because they measured other outcomes. Every claim was copied word for word into the Longevity Circle ledger and checked against the original text, and a person approved each one. Certainty follows the GRADE levels used in medical reviews. Drafting was assisted by AI.

Changelog: 23 Sep 2026, first version, 7 sources.